BOSTON – In the three months since Johnson & Johnson's COVID-19 vaccine received emergency use authorization from the U.S. Food and Drug Administration,.
Tech Moves: Adaptive Biotech co-founders join life sciences SPAC; new edtech execs; and more
April 15, 2021 at 4:44 pm
Underwritten by
Tech Moves covers notable hires, promotions and personnel changes in the Pacific NW tech community. Submissions: tips@geekwire.com
Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, a theoretical physicist turned computational biologist who is the company’s chief scientific officer. (Adaptive Biotechnologies Photo) Adaptive Biotechnologies co-founders and brothers Chad and Harlan Robins are among the directors of a new life sciences SPAC.
The blank check company is called CM Life Sciences III Inc. and listed on the NASDAQ starting April 7. The SPAC is targeting companies in “three separate areas of the life sciences industry that are often fragmented life sciences tools, synthetic biology and diagnostics.”
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Adaptive Biotechnologies fourth quarter financial results conference call. [Operator instructions] I would now like to hand the conference over to your speaker today, Ms. Karina Calzadilla. Thank you.
Please go ahead.
Karina Calzadilla
Thank you, Jeff, and good afternoon, everyone. I would like to welcome you to Adaptive Biotechnologies fourth quarter and full-year 2020 earnings conference call. Earlier today, we issued a press release reporting Adaptive financial results for the fourth quarter and full year of 2020. The press release is available at adaptivebiotech.com.
We are conducting a live webcast of this call and will be referencing to a slide presentation that has been posted to the Investors section in our corporate website. During the call, management will make projections and other forward-looking statements within the meaning of federal securities laws regarding future events and the future